COA / COA-2026-0204
KLOW 50/10/10/10 mg
Lot COA-2026-0204
99.80% (3-vial average)HPLC
Report date
2026-09-03
Testing lab
AV Analytics
Appearance
Lyophilized
| Analyte | Method | Result |
|---|---|---|
| Purity | UPLC-UV + UPLC-MS | 99.80% (3-vial average) |
| Identity | UPLC-UV + UPLC-MS | Conforms (UPLC-MS ionization profile match) |
| Net peptide content | UPLC-UV + UPLC-MS | Vial 1 GHK 52.37 / KPV 9.85 / BPC 10.33 / TB 11.13 · Vial 2 GHK 51.16 / KPV 10.18 / BPC 10.11 / TB 9.92 · Vial 3 GHK 49.97 / KPV 10.06 / TB 10.69 mg (vial 3 BPC not printed) |
| Endotoxin | LAL, USP <85> | Pass (rFC, <0.5 EU/mL; vials 0.21/0.09/0.14) |
Independent analysis by AV Analytics. Results apply to the stated lot. For laboratory and research use only — not for human or animal consumption.